MOHIT KHERA

Concepts (326)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Testosterone
78
2025
559
15.650
Why?
Erectile Dysfunction
38
2025
200
13.100
Why?
Hypogonadism
51
2024
296
12.900
Why?
Hormone Replacement Therapy
37
2025
203
8.310
Why?
Prostatic Neoplasms
33
2025
1551
5.850
Why?
Penile Prosthesis
11
2024
40
4.190
Why?
Androgens
17
2021
280
4.170
Why?
Penile Implantation
8
2024
25
3.760
Why?
Prostatectomy
20
2022
345
2.750
Why?
Prostate-Specific Antigen
13
2025
257
2.380
Why?
Penile Induration
5
2024
37
2.340
Why?
Penile Erection
16
2023
82
2.330
Why?
Cardiovascular Diseases
20
2025
1972
2.240
Why?
Male
132
2025
62009
2.140
Why?
Sexual Dysfunction, Physiological
7
2024
83
1.640
Why?
Libido
5
2022
36
1.640
Why?
Patient Satisfaction
9
2025
477
1.580
Why?
Stem Cell Transplantation
3
2024
237
1.560
Why?
Penis
10
2025
101
1.460
Why?
Humans
136
2025
126285
1.450
Why?
Urology
4
2024
79
1.360
Why?
Sexual Behavior
9
2024
238
1.250
Why?
Depression
5
2018
1245
1.050
Why?
Aged
43
2025
19960
0.980
Why?
Holistic Health
1
2025
11
0.940
Why?
Middle Aged
48
2025
27028
0.930
Why?
Finasteride
2
2022
20
0.920
Why?
Platelet-Rich Plasma
1
2024
15
0.920
Why?
Microbial Collagenase
1
2024
11
0.910
Why?
Watchful Waiting
1
2025
71
0.910
Why?
Sexual Health
1
2024
9
0.870
Why?
Androgen Antagonists
2
2024
121
0.860
Why?
Hyperbaric Oxygenation
1
2023
23
0.860
Why?
Chemical and Drug Induced Liver Injury
1
2025
110
0.860
Why?
Health Care Costs
3
2018
376
0.860
Why?
Reproductive Health
1
2024
42
0.840
Why?
Prosthesis Design
4
2024
673
0.780
Why?
Urinary Sphincter, Artificial
1
2021
5
0.760
Why?
Urinary Incontinence, Stress
1
2021
31
0.750
Why?
5-alpha Reductase Inhibitors
1
2021
14
0.730
Why?
Surveys and Questionnaires
12
2025
3715
0.730
Why?
Fellowships and Scholarships
1
2024
286
0.730
Why?
Cystic Fibrosis
1
2024
258
0.720
Why?
Telemedicine
2
2024
448
0.690
Why?
Polycythemia
1
2020
44
0.680
Why?
Treatment Outcome
23
2024
12379
0.680
Why?
Eunuchism
2
2022
7
0.670
Why?
Retrospective Studies
23
2025
16514
0.650
Why?
Adult
33
2025
29791
0.630
Why?
Curriculum
1
2024
735
0.620
Why?
Fertility
2
2018
259
0.620
Why?
Prostate
4
2023
433
0.610
Why?
Clomiphene
1
2018
12
0.600
Why?
North America
7
2024
245
0.600
Why?
Spinal Cord Injuries
3
2007
303
0.600
Why?
Botulinum Toxins, Type A
3
2005
167
0.580
Why?
Selective Estrogen Receptor Modulators
1
2017
60
0.560
Why?
Aromatase Inhibitors
1
2017
76
0.550
Why?
Societies, Medical
5
2024
709
0.550
Why?
Varicocele
4
2010
60
0.520
Why?
Quality of Life
7
2024
1954
0.520
Why?
Prospective Studies
12
2025
6175
0.500
Why?
Antineoplastic Agents, Hormonal
1
2017
257
0.500
Why?
Abdominal Wall
1
2015
33
0.480
Why?
Postoperative Complications
7
2024
3078
0.470
Why?
Impotence, Vasculogenic
2
2014
9
0.460
Why?
Comorbidity
7
2018
1542
0.450
Why?
Drug Implants
5
2015
42
0.450
Why?
Men's Health
3
2024
20
0.450
Why?
Mesenchymal Stem Cell Transplantation
1
2015
87
0.450
Why?
Randomized Controlled Trials as Topic
3
2024
1129
0.440
Why?
Prostatic Hyperplasia
3
2023
117
0.430
Why?
United States
18
2023
10988
0.430
Why?
Urinary Bladder
2
2005
239
0.430
Why?
Sexual Dysfunctions, Psychological
2
2013
41
0.420
Why?
Medication Adherence
1
2018
401
0.420
Why?
Pandemics
1
2021
1129
0.420
Why?
Extracorporeal Shockwave Therapy
2
2024
9
0.410
Why?
Registries
9
2018
1453
0.400
Why?
Osteoporotic Fractures
1
2012
26
0.390
Why?
Patient Acceptance of Health Care
1
2016
431
0.390
Why?
Carcinoma
1
2015
290
0.390
Why?
Urologic Diseases
2
2023
44
0.380
Why?
Brachytherapy
1
2012
75
0.370
Why?
Klinefelter Syndrome
1
2011
17
0.370
Why?
Aging
2
2016
1208
0.360
Why?
Deficiency Diseases
1
2011
11
0.360
Why?
Phosphodiesterase Inhibitors
1
2011
52
0.360
Why?
Heart Diseases
1
2016
503
0.360
Why?
Coitus
2
2025
20
0.360
Why?
Patient Compliance
2
2011
471
0.340
Why?
Public Health
1
2012
269
0.340
Why?
Risk Factors
12
2021
10372
0.340
Why?
Aged, 80 and over
12
2023
6645
0.330
Why?
Nitric Oxide
1
2013
487
0.330
Why?
Prevalence
4
2018
2483
0.330
Why?
Insulin-Like Growth Factor I
1
2011
343
0.320
Why?
Medicare
5
2023
433
0.310
Why?
Urologic Surgical Procedures, Male
3
2019
36
0.310
Why?
Mass Screening
1
2015
785
0.310
Why?
Estradiol
4
2021
528
0.310
Why?
Cardiovascular System
3
2021
109
0.310
Why?
Disease Progression
3
2025
2103
0.290
Why?
Administration, Oral
3
2025
701
0.290
Why?
Operative Time
3
2018
167
0.280
Why?
Gels
4
2023
70
0.280
Why?
Rats, Sprague-Dawley
6
2015
1261
0.280
Why?
Cell Proliferation
1
2014
2393
0.280
Why?
Receptors, Epoprostenol
1
2007
15
0.270
Why?
Databases, Factual
3
2023
1193
0.270
Why?
Urinary Bladder, Overactive
1
2007
29
0.260
Why?
Urinary Bladder, Neurogenic
1
2007
45
0.260
Why?
Linear Models
3
2013
694
0.260
Why?
Behavior Therapy
2
2023
262
0.260
Why?
Incidence
5
2021
3166
0.260
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2022
735
0.260
Why?
Urinary Incontinence
1
2006
71
0.250
Why?
Neoplasm Grading
3
2021
278
0.250
Why?
Sensation
1
2005
59
0.240
Why?
Neurotoxins
1
2005
56
0.240
Why?
Mice, Nude
2
2017
723
0.230
Why?
Sexology
1
2024
3
0.230
Why?
Network Meta-Analysis
1
2024
28
0.230
Why?
Urethral Stricture
1
2004
13
0.230
Why?
Spermatogenesis
2
2018
170
0.230
Why?
Injections, Intralesional
1
2024
48
0.230
Why?
Cell Line, Tumor
3
2017
3445
0.230
Why?
Rats
6
2020
3762
0.230
Why?
Animals
11
2023
34519
0.220
Why?
Cosmetic Techniques
1
2024
11
0.220
Why?
Diabetes Mellitus, Type 2
2
2023
1282
0.220
Why?
Female
12
2024
67310
0.220
Why?
Blood Pressure
3
2021
1357
0.220
Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2024
44
0.220
Why?
Adenosine Triphosphate
1
2004
281
0.220
Why?
Urinary Retention
1
2023
18
0.220
Why?
Health Expenditures
2
2016
106
0.210
Why?
Neuromuscular Agents
1
2004
67
0.210
Why?
Alprostadil
2
2016
27
0.210
Why?
Patient Preference
1
2025
122
0.210
Why?
Bayes Theorem
1
2024
288
0.210
Why?
Neurocognitive Disorders
1
2024
68
0.210
Why?
Time Factors
4
2024
6334
0.210
Why?
Practice Guidelines as Topic
4
2017
1274
0.200
Why?
Receptors, Androgen
3
2014
415
0.200
Why?
Drug Administration Schedule
3
2013
730
0.200
Why?
Priapism
1
2022
11
0.200
Why?
Sildenafil Citrate
2
2013
55
0.190
Why?
Insurance Coverage
1
2023
121
0.190
Why?
Life Style
1
2025
423
0.190
Why?
Biopsy
1
2025
1257
0.180
Why?
Young Adult
8
2021
9165
0.180
Why?
Orchiectomy
2
2017
51
0.170
Why?
Traction
1
2019
9
0.160
Why?
Azoospermia
2
2010
46
0.160
Why?
Placenta
1
2023
513
0.160
Why?
Phosphodiesterase 5 Inhibitors
2
2016
34
0.160
Why?
Regenerative Medicine
1
2019
33
0.160
Why?
Single-Blind Method
1
2019
240
0.150
Why?
Dementia
1
2024
460
0.150
Why?
Lipids
3
2023
524
0.150
Why?
Insurance, Health
1
2019
141
0.150
Why?
Reoperation
1
2021
835
0.150
Why?
Anemia, Sickle Cell
1
2022
333
0.150
Why?
Hypothalamo-Hypophyseal System
1
2018
65
0.150
Why?
Organ Transplantation
1
2020
170
0.150
Why?
Hematocrit
2
2021
114
0.150
Why?
Chorionic Gonadotropin
1
2018
78
0.150
Why?
Estrogen Antagonists
1
2018
103
0.150
Why?
Sex Hormone-Binding Globulin
3
2014
40
0.140
Why?
Double-Blind Method
3
2023
1611
0.140
Why?
Health Status
2
2010
385
0.140
Why?
Caffeine
1
2018
67
0.140
Why?
Exercise
1
2023
828
0.140
Why?
Recovery of Function
4
2022
438
0.140
Why?
Biomarkers, Tumor
2
2015
1558
0.140
Why?
Tumor Burden
1
2017
236
0.130
Why?
Gene Expression
1
2021
1560
0.130
Why?
Diabetes Complications
2
2015
203
0.130
Why?
Dosage Forms
1
2016
9
0.130
Why?
Administration, Cutaneous
2
2013
66
0.130
Why?
Clinical Decision-Making
1
2018
267
0.130
Why?
Thrombosis
1
2021
524
0.120
Why?
Cohort Studies
4
2020
4873
0.120
Why?
Fasciotomy
1
2015
26
0.120
Why?
Follow-Up Studies
4
2021
5199
0.120
Why?
Age Distribution
1
2016
422
0.120
Why?
Personal Satisfaction
2
2013
103
0.120
Why?
Endothelium, Vascular
2
2017
490
0.120
Why?
Heterografts
1
2015
179
0.120
Why?
Radiotherapy, Adjuvant
1
2015
145
0.120
Why?
Heart Rate
1
2017
583
0.120
Why?
Vulvodynia
1
2014
2
0.120
Why?
Luteinizing Hormone
4
2015
131
0.120
Why?
Lower Urinary Tract Symptoms
1
2015
36
0.120
Why?
Biomarkers
2
2015
3153
0.110
Why?
Cost-Benefit Analysis
2
2015
517
0.110
Why?
Contraceptives, Oral, Hormonal
1
2014
19
0.110
Why?
Endocrinology
1
2017
134
0.110
Why?
Xenograft Model Antitumor Assays
1
2017
918
0.110
Why?
History, 21st Century
1
2015
271
0.110
Why?
Nanostructures
1
2014
52
0.110
Why?
Case-Control Studies
1
2021
3341
0.110
Why?
History, 20th Century
1
2015
389
0.110
Why?
Osteoporosis
1
2015
119
0.110
Why?
Reproduction
1
2016
239
0.110
Why?
Androgen-Insensitivity Syndrome
1
2013
27
0.110
Why?
Postoperative Period
3
2022
338
0.110
Why?
Bone Density
1
2016
324
0.110
Why?
Nitric Oxide Synthase
2
2016
176
0.110
Why?
Streptozocin
1
2013
25
0.110
Why?
Infertility, Male
2
2015
280
0.100
Why?
Microspheres
1
2013
72
0.100
Why?
Disease Management
1
2017
529
0.100
Why?
Adolescent
5
2022
19531
0.100
Why?
Sulfones
1
2013
74
0.100
Why?
Body Composition
1
2016
532
0.100
Why?
Purines
1
2013
116
0.100
Why?
Decision Making
1
2018
671
0.100
Why?
Education, Medical, Continuing
1
2014
143
0.100
Why?
Health Surveys
2
2011
247
0.100
Why?
Pregnancy
2
2023
7257
0.100
Why?
Vascular Diseases
1
2014
156
0.100
Why?
Nitric Oxide Synthase Type III
1
2013
199
0.100
Why?
Risk Assessment
2
2021
3459
0.100
Why?
Diabetes Mellitus, Experimental
1
2013
139
0.100
Why?
Pilot Projects
1
2016
1413
0.090
Why?
Statistics, Nonparametric
1
2013
435
0.090
Why?
Tadalafil
1
2011
4
0.090
Why?
Piperazines
1
2013
242
0.090
Why?
Hemoglobins
1
2013
315
0.090
Why?
Prosthesis-Related Infections
1
2013
174
0.090
Why?
Polymorphism, Genetic
1
2014
820
0.090
Why?
Practice Patterns, Physicians'
1
2017
740
0.090
Why?
Muscle Contraction
2
2016
188
0.090
Why?
Insulin Resistance
1
2016
645
0.090
Why?
Analysis of Variance
1
2013
1019
0.090
Why?
Sexual Partners
1
2011
87
0.090
Why?
Logistic Models
2
2018
1811
0.090
Why?
Drug Monitoring
1
2012
174
0.090
Why?
Chronic Disease
2
2005
1204
0.090
Why?
Body Mass Index
2
2018
1582
0.090
Why?
Risk
1
2012
769
0.090
Why?
Cause of Death
1
2012
477
0.080
Why?
Clinical Protocols
1
2011
240
0.080
Why?
Health Status Indicators
1
2010
123
0.080
Why?
Sexuality
1
2009
12
0.080
Why?
Drug Therapy, Combination
1
2013
1168
0.080
Why?
Organ Size
1
2010
444
0.080
Why?
Program Development
1
2010
182
0.080
Why?
Mice
2
2017
17864
0.080
Why?
Pregnancy Outcome
1
2012
599
0.080
Why?
Patient Safety
1
2014
400
0.080
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2009
6
0.080
Why?
Vasodilator Agents
1
2010
203
0.080
Why?
Survival Analysis
1
2012
1515
0.080
Why?
Age Factors
4
2019
2834
0.080
Why?
Evidence-Based Medicine
3
2017
635
0.080
Why?
Veins
1
2009
104
0.070
Why?
Cross-Sectional Studies
2
2018
3456
0.070
Why?
Laparoscopy
2
2013
495
0.070
Why?
Preoperative Care
1
2010
358
0.070
Why?
Analgesics, Opioid
1
2012
417
0.070
Why?
Embolization, Therapeutic
1
2009
219
0.070
Why?
Odds Ratio
1
2010
1266
0.070
Why?
Disease Models, Animal
1
2017
4466
0.070
Why?
Sex Factors
1
2010
1292
0.070
Why?
International Cooperation
2
2017
160
0.060
Why?
Masturbation
1
2025
2
0.060
Why?
Recurrence
2
2009
1397
0.060
Why?
Constriction
1
2025
50
0.060
Why?
Urothelium
1
2004
57
0.060
Why?
Retreatment
1
2004
91
0.060
Why?
Vascular Surgical Procedures
1
2009
550
0.060
Why?
Follicle Stimulating Hormone
2
2015
187
0.060
Why?
Transdermal Patch
1
2023
8
0.050
Why?
Severity of Illness Index
1
2011
2933
0.050
Why?
Phenylephrine
1
2022
38
0.050
Why?
Testosterone Congeners
1
2022
16
0.050
Why?
Isotretinoin
1
2022
23
0.050
Why?
Monitoring, Ambulatory
1
2021
55
0.040
Why?
Prosthesis Failure
1
2022
157
0.040
Why?
HIV Infections
1
2013
1908
0.040
Why?
SEER Program
1
2021
205
0.040
Why?
Antidepressive Agents
1
2022
299
0.040
Why?
Waist Circumference
1
2018
90
0.040
Why?
United States Food and Drug Administration
1
2018
152
0.030
Why?
Critical Pathways
1
2018
79
0.030
Why?
Polypharmacy
1
2017
40
0.030
Why?
Neoplasm Staging
1
2021
1291
0.030
Why?
Survival Rate
1
2022
2068
0.030
Why?
Premature Ejaculation
1
2016
4
0.030
Why?
Child
3
2022
24740
0.030
Why?
Nutrition Surveys
1
2018
298
0.030
Why?
Muscle, Smooth
1
2016
135
0.030
Why?
Proportional Hazards Models
1
2019
1378
0.030
Why?
Patient Participation
1
2018
225
0.030
Why?
Myocardial Infarction
1
2023
1054
0.030
Why?
Stroke
1
2023
995
0.030
Why?
2-Hydroxypropyl-beta-cyclodextrin
1
2014
4
0.030
Why?
beta-Cyclodextrins
1
2014
12
0.030
Why?
Luminescent Measurements
1
2014
58
0.030
Why?
Trinucleotide Repeats
1
2014
108
0.030
Why?
Manometry
1
2014
60
0.030
Why?
Patient Admission
1
2015
186
0.030
Why?
Ultrasonography, Doppler, Duplex
1
2014
43
0.030
Why?
Drug Delivery Systems
1
2014
206
0.030
Why?
Arteries
1
2014
218
0.030
Why?
Canada
1
2013
291
0.020
Why?
Kinetics
1
2014
1327
0.020
Why?
Robotics
1
2013
106
0.020
Why?
Clinical Trials as Topic
1
2016
1111
0.020
Why?
Body Weights and Measures
1
2011
42
0.020
Why?
Reference Values
1
2012
722
0.020
Why?
Patient Selection
1
2014
703
0.020
Why?
Affect
1
2011
157
0.020
Why?
Alleles
1
2014
1624
0.020
Why?
Ligation
1
2009
134
0.020
Why?
Genotype
1
2014
2593
0.020
Why?
Hospital Costs
1
2009
180
0.020
Why?
Algorithms
1
2015
1647
0.020
Why?
Equipment Design
1
2009
595
0.020
Why?
Metabolic Syndrome
1
2011
346
0.020
Why?
Radiography
1
2009
805
0.020
Why?
Blood Glucose
1
2011
1142
0.020
Why?
Obesity
1
2011
2276
0.010
Why?
KHERA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (326)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_